MENU
HYPD
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Hyperion DeFi (HYPD) Ownership - Who owns Hyperion DeFi?
Hyperion DeFi Inc is a clinical-stage ophthalmic company developing a pipeline of therapeutics based on its proprietary array print (MAP) platform technology... Show more
Industry: #Pharmaceuticals Major
Profile
Industry
Pharmaceuticals Major
Address
N/A
Phone
N/A
Employees
N/A
Web
N/A
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
35.08M
P/E Ratio
N/A
Total Cash
7.53M
Projected Growth
N/A
Total Debt
8.47M
Revenue
44.44K
Risk (Beta)
3.49
Dividend Yield
N/A
Total Cash/Share
1.32
Total Debt/Equity
N/A
Revenue/Share
0.02 USD as % of share price
Fundamentals
HYPD
Capitalization
35.1M
P/E Ratio
N/A
Risk (Beta)
3.49
Dividend Yield
N/A
Total Cash
7.53M
Total Cash/Share
1.32
Total Debt
8.47M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.02%
Revenue
44.4K
ROE
N/A
Book Value
37.4M
P/B Ratio
0.94
Cash Flow
N/A
Earnings
-28.84
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
485
Current Ratio
0.91
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-37.19M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-107.47
Shares Held By Institutions
1.23M
Shares Outstanding - Current
5.7M
Total Liabilities
18.3M
Total Volume MTD
N/A
Value
N/A
Gain YTD
4119.178
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
A.I. Advisor
published General Information
General Information
a company which delivers sight saving therapies
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
N/A
Phone
N/A
Employees
N/A
Web
N/A